Generated by AI
Inogen Inc. is a medical technology company focused on respiratory care for people living with chronic respiratory conditions. The company develops, manufactures, and markets portable oxygen concentrators for homecare use, helping patients receive supplemental long-term oxygen therapy in a more mobile form than traditional oxygen systems. Its product portfolio also includes stationary home oxygen concentrators, batteries, accessories, rental offerings, and airway-clearance solutions. Inogen serves patients through direct-to-consumer, business-to-business, and international channels, working with home medical equipment providers, prescribers, and distributors to broaden access to respiratory therapy products. Headquartered in Beverly, Massachusetts, Inogen plays a specialized role in the respiratory health market by addressing everyday oxygen therapy needs across home, travel, and other ambulatory settings.
Website500 Cummings Center
Beverly, MA, 01915
United States
The latest articles about INGN.
Inogen Inc (INGN) posted its first US sales growth since Q4 2024, closed its rental business divestiture, and unveiled $20 million in new annualized cost savings despite a 2.4% revenue decline.
Summary of Jul 24's posts. Generated by AI.
Summary of Feb 24's posts. Generated by AI.
Summary of Jul 22's posts. Generated by AI.
Investors talking about INGN also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.